Slide 1: Welcome to the 1Q22 Webinar
Welcome to the 1Q22 Webinar modulight
Slide 2: Today’s agenda
Today’s agenda q 1Q22 in brief q Project pipeline development q Progress with investments q Q&A Memorial Sloan Kettering, New York (Feb-22) 2
Slide 3: Good progress with pipeline, revenue and profitability lower
Good progress with pipeline, revenue and profitability lower q Good development continued with project pipeline v Modulight initiated two new projects (one from top-5 pharma & public company), good progress in existing portfolio v Successful recruiting of new employees continues, especially for anal
Slide 4: Key figures
Key figures Key Figures1) (thousand euro, unless stated otherwise) 1-3/2022 1-3/2021 Change 1-12/20212) Revenue 1,601 2,204 -27.4 % 9,071 EBITDA -418 1,379 -130.3 % 461 EBITDA-% -26.1 % 62.6 % -77.0 % 5.1 % Operating result (EBIT) -869 1,128 -177.0 % - 753 Operating result (EBIT), % of revenue -54.3
Slide 5: Project portfolio continues to expand
Project portfolio continues to expand Total number of project with commercialization potential In 1Q22 we initiated two new projects with 25 significant customers (top-5 pharma & another public company) New projects during the quarter 20 q Wins highlight the recognition of Modulight’s expertise and
Slide 6: New projects started in 1Q22
New projects started in 1Q22 “Both wins highlight the recognition of Modulight’s expertise and the broadening potential and diverse usability of the company’s technology Customer: One of the worlds five largest Customer: established US public platforms, as well as further pharmaceutical companies co
Slide 7: Modulight’s customer base – pipeline projects
Modulight’s customer base – pipeline projects Ownership Maturity Size 30 30 30 25 25 25 20 20 20 15 15 15 10 10 10 5 5 5 0 0 1Q21 2Q21 3Q21 4Q21 1Q22 1Q21 2Q21 3Q21 4Q21 1Q/ 22 0 1Q21 2Q21 3Q21 4Q21 1Q22 Listed company Research Research Early stage Private companies Other companies Established >1bn
Slide 8: A typical project
A typical project CASE EXAMPLE: Generic Modulight customer project flow Customer contacts Modulight 6 – 24 months 3 – 5 years 5 – 10 years Sales cycles vary – Typical projects Project plans are often ambitious - New cancer GTM phase – often months start with early delays are common due to many thera
Slide 9: Scheduled FDA on-site audit begun in April
Scheduled FDA on-site audit begun in April CASE EXAMPLE “After period-end in Treating age-related eye diseases April, the FDA officials § Modulight is developing a photodynamic laser made their first audit therapy (PDT) solution in collaboration with a major pharmaceutical company listed on related
Slide 10: Progress with clinical trial phase projects
Progress with clinical trial phase projects CASE EXAMPLE Brain diagnostics § Modulight has delivered last year prototypes of “A good example of lasers to customer working with brain diagnostics. These prototypes are same as Modulight’s deep products delivered earlier to existing genomics customers;
Slide 11: Progress with clinical trial phase projects (cont’)
Progress with clinical trial phase projects (cont’) CASE EXAMPLE Bladder cancer § Last year Modulight landed a contract with a “We have successfully long-time existing customer to develop solution for bladder cancer including cystoscope continued our efforts adapter for our platform device 7710. Sev
Slide 12: Growth strategy implementation accelerated
Growth strategy implementation accelerated Factory Illustrati photo? on? Successful recruitment Capacity expansion Capability expansion Especially for analytics and On track and on-budget On track, budget & wider scope software engineering 12
Slide 13: Business objectives and dividend policy
Business objectives and dividend policy Long Term Objectives Dividend Policy Business Objective: Financial Objectives: Proceed to large-scale Maintain strong Maintain strong In the coming years, Modulight commercial deployment1 with revenue growth profitability will focus on financing the company’s
Slide 14: Outlook
Outlook Modulight has not issued a guidance for revenue or profitability in 2022. As the company’s customer projects are still distributed across different, varying early stages of development and predicting developments in the market remains challenging, it is difficult to forecast performance in 2
Slide 15: Greetings from the Q1 exhibits
Greetings from the Q1 exhibits 15
Slide 16: Thank you! Questions?
Thank you! Questions? LEARN MORE AND FOLLOW US IN TWITTER, FACEBOOK, YOUTUBE AND INSTAGRAM: 16